BREAKOUT STOCK ALERT
SYBX - Synlogic, Inc. - Common Stock
Initial Price: $2.50
Potential Price: $2.80
Potential Gains: 12%
Stop Loss Limit: $2.38
SYBX EMA Crossover going green for the first time since $4.00 High on Nov. 25th after the U.S. government has agreed to loan Synlogic partner Ginko Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address future pandemics. We're looking for a small $2.80-$3.00 Fibonacci Retracement Bounce over the course of the next day for a nice 12-20% return. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
SYBX - Synlogic, Inc. - Common StockInitial Price: $2.50
Potential Price: $2.80
Potential Gains: 12%
Stop Loss Limit: $2.38
SYBX EMA Crossover going green for the first time since $4.00 High on Nov. 25th after the U.S. government has agreed to loan Synlogic partner Ginko Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address future pandemics. We're looking for a small $2.80-$3.00 Fibonacci Retracement Bounce over the course of the next day for a nice 12-20% return. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Trade active
BREAKOUT STOCK ALERT UPDATESYBX - Synlogic, Inc. - Common StockInitial Alert Price: $2.50
Price High: $3.97
% Gains/Losses: 58.8%
(58.68% More Than Expected)
Stop Loss Limit: $3.77
SYBX EMA Crossover going green for the first time since $4.00 High on Nov. 25th after the U.S. government has agreed to loan Synlogic partner Ginko Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address future pandemics. We're looking for a small $2.80-$3.00 Fibonacci Retracement Bounce over the course of the next day for a nice 12-20% return. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.